Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dakin's Solution for Prevention of Radiation Dermatitis in Breast Cancer
NCT02203565Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jul 2014
- Primary completion
- Jul 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium hypochlorite in radiation dermatitis, sponsored by Stanford University. Started Jul 2014; status: completed.
02
Drugs
sodium hypochlorite
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT02203565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203565.